Figure 1
Flowchart of breast cancer patients included in the TailorDose I study, based on given dose of cyclophosphamide per body surface area during three treatment courses.
Figure 1 | Scientific Reports
Flowchart of breast cancer patients included in the TailorDose I study, based on given dose of cyclophosphamide per body surface area during three treatment courses.
